-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BSbBmFbu9ORHyuMxs7F7IQOVtzpU6+uz0P55TieNm1ykdUK7BLQv2NNrjDw3riWR J9C/Ba52v2JmQ4I/Lcaczg== 0000731766-09-000032.txt : 20090225 0000731766-09-000032.hdr.sgml : 20090225 20090225214438 ACCESSION NUMBER: 0000731766-09-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090223 FILED AS OF DATE: 20090225 DATE AS OF CHANGE: 20090225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOUDREAUX GAIL CENTRAL INDEX KEY: 0001287920 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10864 FILM NUMBER: 09635433 MAIL ADDRESS: STREET 1: GENZYME CORP. STREET 2: 500 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITEDHEALTH GROUP INC CENTRAL INDEX KEY: 0000731766 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 411321939 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UNITEDHEALTH GROUP CENTER STREET 2: 9900 BREN ROAD EAST CITY: MINNEAPOLIS STATE: MN ZIP: 55343 BUSINESS PHONE: 9529361300 MAIL ADDRESS: STREET 1: 9900 BREN ROAD EAST CITY: MINNETONKA STATE: MN ZIP: 55343 FORMER COMPANY: FORMER CONFORMED NAME: UNITED HEALTHCARE CORP/ DATE OF NAME CHANGE: 20000309 FORMER COMPANY: FORMER CONFORMED NAME: UNITED HEALTHCARE CORP DATE OF NAME CHANGE: 19920703 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2009-02-23 0 0000731766 UNITEDHEALTH GROUP INC UNH 0001287920 BOUDREAUX GAIL C/O UNITEDHEALTH GROUP INCORPORATED 9900 BREN ROAD EAST MINNETONKA MN 55343 0 1 0 0 EVP & Pres, UnitedHealthcare Common Stock 2009-02-23 4 A 0 38462 0 A 171017 D Stock Appreciation Rights 29.74 2009-02-23 4 A 0 113122 0 A 2010-02-03 2019-02-23 Common Stock 113122 113122 D The restricted stock units will vest at a rate of 25% annually on February 3 from the years 2010 through 2013. Amount does not include performance-based restricted stock units granted to the executive officer on February 23, 2009, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of average EPS growth percentanges and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 76,923. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013. By: Dannette L. Smith, Attorney-in-Fact For: Gail Koziara Boudreaux 2009-02-24 -----END PRIVACY-ENHANCED MESSAGE-----